Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia

Gynecologic Oncology

Volumn 64, Issue 1, 1997, Pages 70-75

  Monk, Bradley J ^a,d   Brewer, Cheryl ^a   VanNostrand, Kristi ^a   Berns, Michael W ^b   McCullough, Jerry L ^c   Tadir, Yona ^a,b   Manetta, Alberto ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; LAUROCAPRAM; PHOTOFRIN II;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLPOSCOPY; DRUG EFFICACY; DRUG SAFETY; DYE LASER; ENERGY; FEMALE; HUMAN; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VAGINA DISCHARGE;

EID: 0031013159     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4463     Document Type: Article

References (30)

1. 1. Parkin, D.M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985, Int. J. Cancer, 54, 594-606 (1993).
2. 2. Muñoz, N., and Bosch, F. X. Epidemiology of cervical cancer, in Human papillomavirus and cervical cancer (N. Muñoz, F. X. Bosch, O. M. Jensen, Eds.), International Agency for Research on Cancer Scientific Publications, No. 94, Lyon, pp. 9-39 (1989).
3. 3. Miller, A. B. Control of carcinoma of cervix by exfoliative cytology screening, in Gynecologic oncology: Fundamental principles and clinical practice (M. Coppleson, Ed.), Churchill Livingstone, Edinburgh, 2nd ed., pp. 543-556 (1992).
4. 4. DiSaia, P. J., and Creasman, W. T. Preinvasive disease of the cervix, in Clinical gynecologic oncology Mosby Year Book, St. Louis, 4th ed., pp. 1-36 (1993).
5. 5. Coppleson, M., Atkinson, K. H., and Dalrymple, J. C. Cervical squamous and glandular intraepithelial neoplasia: Clinical features and review of management, in Gynecologic oncology: Fundamental principles and clinical practice (M. Coppleson, Ed.), Churchill Livingstone, Edinburgh, 2nd ed., pp. 571-608 (1992).
6. 6. Dougherty, T. J. Photodynamic therapy(PDT) of malignant tumors, Crit. Rev. Oncol. Hematol 2, 83-116 (1984).
7. 7. Kretmer-Birnbaum, M. Modified prophyrins, chlorins, phtalocyanines, and purpurines: Second generation photosensitizers for photodynamic therapy, Semin. Hematol. 26, 157-173 (1989).
8. 8. Kimel, S., Tromberg, B. J., Roberts, W. G., and Berns, M. W. Singlet oxygen generation of porphyrins, chlorins, and phthalocyanines, Photochem. Photobiol. 50, 175-183 (1989).
9. 9. Chapman, J. A., Tadir, T., Tromberg, B. J., Yu, K., Manetta, A., Sun, C. H., and Berns, M. W. Effect of administration route and estrogen manipulation on endometrial uptake of Photofrin, Am. J. Obstet. Gynecol. 168, 685-692 (1993).
10. 14C] hematoporphyrin derivative distribution in malignant and normal tissue, Cancer Res. 39, 146-151 (1979).
11. 11. Spitzer, M., and Krumholz, B. A. Photodynamic therapy in gynecology, Obstet. Gynecol. Clin. North Am. 18, 649-659 (1991).
12. 12. Kato, H., Horai, T., Furuse, K., Fukuoka, M., Suzuki, S., Hiki, Y., Ito, Y., Mimura, S., Tenjin, Y., Hisazumi, H., et al. Photodynamic therapy for cancers: A clinical trial of porfimer sodium in Japan, Jpn. J. Cancer Res. 84, 1209-1214 (1993).
13. 13. Laws, E. R., Cortese, D. A., Kinsey, J. H., Eagan, R. T., and Anderson, R. E. Photoradiation therapy in the treatment of malignant brain tumors: a phase 1 (feasibility) study, Neurosurgery 9, 672-678 (1981).
14. 14. Hisazumi, H., Misaki, T., and Miyoshi, N. Photoradiation therapy of bladder tumors, J. Urol. 130, 685-687 (1983).
15. 15. Hayata, Y., Kato, H., Okitsu, H., Kawaguchi, M., and Konaka, C. Photodynamic therapy with hematoporphyrin derivative in cancer in the upper gastrointestinal tract, Surg. Oncol. 1, 1-11 (1985).
16. 16. Rettenmaier, M. A., Berman, M. L., DiSaia, P. J., Burns, R. G., Weinstein, G. D., McCullough, J. L., and Berns, M. W. Gynecologic uses of photoradiation therapy, in Porphyrin localization and treatment of tumors (D. R. Doiron and C. J. Gomer, Eds.), A. R. Liss, New York, pp. 767-775 (1984).
17. 17. Hetzel, H., Muller-Holzner, E., Marth, C., and Kostron, H. Photodynamic therapy in patients with recurrent gynecologic cancers, Geburts. Frauenheil. 53, 333-336 (1993). [in German]
18. 18. Lele, S. B., Piver, M. S., Mang, T. S., Dougherty, T. J., and Tomczak, M. J. Photodynamic therapy in gynecologic malignancies, Gynecol. Oncol. 34, 350-352 (1989).
19. 19. Caughan, J. S., Schellhas, H. F., Lomano, J., and Bethel, B. H. Photodynamic therapy of gynecologic neoplasms after presensitization with hematoporphyrin derivative, Lasers Surg. Med. 5, 491-498 (1985).
20. 20. Rettenmaier, M. A., Berman, M. L., DiSaia, P. J., Burns, R. G., and Berns, M. W. Photoradiation therapy of gynecologic malignancies, Gynecol. Oncol. 17, 200-206 (1984).
21. 21. Corti, L., Tomio, L., Maluta, S., Minucci, D., Fontana, M., Cittar, H., et al. Recurring gynaecologic cancer treated with photodynamic therapy, Photochem. Photobiol. 46, 949-952 (1987).
22. 22. Gray, M. J., Lipson, R. L., Maeck, J. V. C., Parker, L., and Romeyn, D. Use of hematoporphyrin derivative in detection and management of cervical cancer, Am. J. Obstet. Gynecol. 99, 766-771 (1967).
23. 23. Sindelar, W. F., Delaney, T. F., Tochner, Z., Thomas, G. F., Dachoswki, L. J., Smith, P. D., et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms, Arch. Surg. 126, 318-324 (1991).
24. 24. Falk, G. W. Barrett's esophagus, Gastroenterol. Endocrinol. Clin. North Am., 4, 773-789 (1994).
25. 25. McCullough, J. L., Weinstein, G. D., and Berns, M. W. Topical hematoporphyrin derivative (HPD) photodynamic therapy for psoriasis, Laser Res. Med. Dent. Surg. 64, 35-39 (1988).
26. 26. Wyss, P., Tromberg, B. J., Wyss, M. T., Krasieva, T., Schell, M., Berns, M. W., and Tadir, Y. Photodynamic destruction of endometrial tissue using topical 5-aminolevulinic acid (5-ALA) in rats and rabbits, Am. J. Obstet. Gynecol. 171, 1176-1183 (1994).
27. 27. Wyss, P., Tadir, Y., Tromberg, B. J., Liaw, L., Krasieva, T., and Berns, M. W. Benzo-Porphyrin derivative (BPD): A potent photosensitizer for photodymanic destruction of the rabbit endometrium, Obstet. Gynecol. 84, 490-414 (1994).
28. 28. McCullough, J. L., Weinstein, G. D., Lemus, L. L., Rampone, W., and Jenkins, J. J. Development of a topical hematoporphyrin derivative formulation: Characterization of photosensitizing effects in vivo, J. Invest. Dermatol 81, 528-532 (1983).
29. 29. Montz, F. J., Monk, B. J., Fowler, J. M., and Nguyen, L. Natural history of the minimally abnormal Papanicolaou smear, Obstet. Gynecol. 80, 385-388 (1992).
30. 30. Richart, R. M., and Wright, T. C. Controversies in the management of low-grade cervical intraepithelial neoplasia, Cancer 71, 1413-1421 (1993).